Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epstein-Barr virus infection in patients with MOGAD.
Maniscalco GT, Dinoto A, Foglia MC, Di Battista ME, Moreggia O, Di Giulio Cesare D, Williams M, Rossi FW, Carta S, Chiodega V, Ferrari S, Viola A, de Paulis A, Andreone V, Mariotto S. Maniscalco GT, et al. Among authors: di battista me. Mult Scler. 2024 Dec 13:13524585241298065. doi: 10.1177/13524585241298065. Online ahead of print. Mult Scler. 2024. PMID: 39668776
Retrospective analysis of a tertiary care centre of sex differences in risk factors, aetiology and short-term clinical outcome after revascularization treatment in young adults' ischemic stroke.
Renna R, Spagnoletti G, Rippa M, Alfieri G, Barbato S, Candelaresi P, Capezzuto C, Della Rocca G, De Mase A, Di Battista ME, Di Giovanni M, Di Iorio W, Longo K, Loreto V, Maurea C, Napolitano M, Petrillo E, Ranieri A, Salvatore S, Servillo G, Spina E, Villani R, Muto M, Andreone V. Renna R, et al. Among authors: di battista me. Neurol Sci. 2024 Nov 18. doi: 10.1007/s10072-024-07859-0. Online ahead of print. Neurol Sci. 2024. PMID: 39551848
Systemic sclerosis: one year in review 2024.
Lepri G, Di Battista M, Codullo V, Bonomi F, Sulis A, Guiducci S, Della Rossa A. Lepri G, et al. Among authors: di battista m. Clin Exp Rheumatol. 2024 Aug;42(8):1517-1528. doi: 10.55563/clinexprheumatol/is29he. Epub 2024 Jul 26. Clin Exp Rheumatol. 2024. PMID: 39058484 Free article. Review.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group. Signoriello E, et al. Among authors: di battista me. Mult Scler Relat Disord. 2024 Jul;87:105594. doi: 10.1016/j.msard.2024.105594. Epub 2024 Apr 6. Mult Scler Relat Disord. 2024. PMID: 38718748 Free article.
119 results